Antiplatelet agents for adults with chronic kidney disease?

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f1392 (Published 6 March 2013)
Cite this as: BMJ 2013;346:f1392

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

OpenUrlMedline

Antiplatelet agents do not prevent deaths from cardiovascular disease or any other cause in adults with chronic kidney disease. In the first comprehensive meta-analysis in this patient group, drugs such as aspirin and clopidogrel reduced the risk of …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL